CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +417 | $15.44 | $6K | 63,860 |
| 2026-05-18 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −417 | $27.55 | $11K | 63,443 |
| 2026-05-18 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −417 | 4,167 | ||
| 2026-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +3,541 | $10.20 | $36K | 73,333 |
| 2026-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +4,166 | $14.25 | $59K | 77,499 |
| 2026-05-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −14,056 | $28.58 | $402K | 63,443 |
| 2026-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −3,541 | 116,876 | ||
| 2026-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −4,166 | 87,501 | ||
| 2026-05-12 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,348 | $1.08 | $7K | 76,140 |
| 2026-05-12 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −6,348 | $29.36 | $186K | 69,792 |
| 2026-05-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −6,348 | 12,698 | ||
| 2026-05-11 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +2,171 | $16.00 | $35K | 71,963 |
| 2026-05-11 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,171 | $29.71 | $65K | 69,792 |
| 2026-05-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −2,171 | 19,535 | ||
| 2026-04-17 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +416 | $15.44 | $6K | 70,208 |
| 2026-04-17 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −416 | $31.33 | $13K | 69,792 |
| 2026-04-17 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −416 | 4,584 | ||
| 2026-04-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −6,348 | $27.66 | $176K | 69,792 |
| 2026-04-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,349 | $1.08 | $7K | 82,489 |
| 2026-04-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +3,542 | $10.20 | $36K | 86,031 |
Page 4 of 17 · 321 trades